9-35808337-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003995.4(NPR2):​c.2713-172C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.289 in 1,518,044 control chromosomes in the GnomAD database, including 66,506 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4932 hom., cov: 32)
Exomes 𝑓: 0.30 ( 61574 hom. )

Consequence

NPR2
NM_003995.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.24

Publications

23 publications found
Variant links:
Genes affected
NPR2 (HGNC:7944): (natriuretic peptide receptor 2) This gene encodes natriuretic peptide receptor B, one of two integral membrane receptors for natriuretic peptides. Both NPR1 and NPR2 contain five functional domains: an extracellular ligand-binding domain, a single membrane-spanning region, and intracellularly a protein kinase homology domain, a helical hinge region involved in oligomerization, and a carboxyl-terminal guanylyl cyclase catalytic domain. The protein is the primary receptor for C-type natriuretic peptide (CNP), which upon ligand binding exhibits greatly increased guanylyl cyclase activity. Mutations in this gene are the cause of acromesomelic dysplasia Maroteaux type. [provided by RefSeq, Jul 2008]
SPAG8 (HGNC:14105): (sperm associated antigen 8) The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein encoded by this gene is recognized by sperm agglutinating antibodies from an infertile woman. This protein is localized in germ cells of the testis at all stages of spermatogenesis and is localized to the acrosomal region of mature spermatozoa. This protein interacts with ACT (activator of CREM in testis) and may play a role in CREM (cAMP response element modulator)-ACT-mediated gene transcription during spermatogenesis. This protein may also play a role in spermatogenesis by regulating microtubule formation and cell division. Alternatively spliced variants that encode different protein isoforms have been described but the full-length sequences of only two have been determined. [provided by RefSeq, Jul 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 9-35808337-C-G is Benign according to our data. Variant chr9-35808337-C-G is described in ClinVar as [Benign]. Clinvar id is 1282017.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.303 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPR2NM_003995.4 linkc.2713-172C>G intron_variant Intron 18 of 21 ENST00000342694.7 NP_003986.2 P20594-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPR2ENST00000342694.7 linkc.2713-172C>G intron_variant Intron 18 of 21 1 NM_003995.4 ENSP00000341083.2 P20594-1

Frequencies

GnomAD3 genomes
AF:
0.231
AC:
35147
AN:
152012
Hom.:
4930
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0713
Gnomad AMI
AF:
0.477
Gnomad AMR
AF:
0.279
Gnomad ASJ
AF:
0.193
Gnomad EAS
AF:
0.154
Gnomad SAS
AF:
0.236
Gnomad FIN
AF:
0.325
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.307
Gnomad OTH
AF:
0.260
GnomAD2 exomes
AF:
0.265
AC:
63791
AN:
241106
AF XY:
0.267
show subpopulations
Gnomad AFR exome
AF:
0.0697
Gnomad AMR exome
AF:
0.285
Gnomad ASJ exome
AF:
0.196
Gnomad EAS exome
AF:
0.142
Gnomad FIN exome
AF:
0.309
Gnomad NFE exome
AF:
0.311
Gnomad OTH exome
AF:
0.266
GnomAD4 exome
AF:
0.295
AC:
403288
AN:
1365914
Hom.:
61574
Cov.:
21
AF XY:
0.294
AC XY:
201246
AN XY:
684642
show subpopulations
African (AFR)
AF:
0.0637
AC:
2008
AN:
31504
American (AMR)
AF:
0.283
AC:
12372
AN:
43684
Ashkenazi Jewish (ASJ)
AF:
0.195
AC:
4977
AN:
25502
East Asian (EAS)
AF:
0.187
AC:
7338
AN:
39232
South Asian (SAS)
AF:
0.243
AC:
20434
AN:
84072
European-Finnish (FIN)
AF:
0.304
AC:
16184
AN:
53162
Middle Eastern (MID)
AF:
0.208
AC:
1164
AN:
5586
European-Non Finnish (NFE)
AF:
0.315
AC:
323325
AN:
1025930
Other (OTH)
AF:
0.271
AC:
15486
AN:
57242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
15525
31050
46575
62100
77625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10056
20112
30168
40224
50280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.231
AC:
35158
AN:
152130
Hom.:
4932
Cov.:
32
AF XY:
0.233
AC XY:
17295
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.0711
AC:
2953
AN:
41504
American (AMR)
AF:
0.279
AC:
4262
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.193
AC:
670
AN:
3472
East Asian (EAS)
AF:
0.154
AC:
801
AN:
5186
South Asian (SAS)
AF:
0.236
AC:
1135
AN:
4818
European-Finnish (FIN)
AF:
0.325
AC:
3428
AN:
10560
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.307
AC:
20848
AN:
67972
Other (OTH)
AF:
0.264
AC:
558
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1342
2684
4025
5367
6709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.199
Hom.:
648
Bravo
AF:
0.220
Asia WGS
AF:
0.239
AC:
831
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
5.8
DANN
Benign
0.77
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3763631; hg19: chr9-35808334; COSMIC: COSV52414358; COSMIC: COSV52414358; API